Rong Wang

4.2k total citations · 1 hit paper
162 papers, 2.6k citations indexed

About

Rong Wang is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Rong Wang has authored 162 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Hematology, 38 papers in Molecular Biology and 35 papers in Genetics. Recurrent topics in Rong Wang's work include Acute Myeloid Leukemia Research (46 papers), Acute Lymphoblastic Leukemia research (24 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (22 papers). Rong Wang is often cited by papers focused on Acute Myeloid Leukemia Research (46 papers), Acute Lymphoblastic Leukemia research (24 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (22 papers). Rong Wang collaborates with scholars based in United States, China and Japan. Rong Wang's co-authors include Xiaomei Ma, Amy J. Davidoff, Rory M. Shallis, Amer M. Zeidan, Amer M. Zeidan, Cary P. Gross, Nikolai A. Podoltsev, Smith Giri, Scott F. Huntington and Jan Philipp Bewersdorf and has published in prestigious journals such as Circulation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Rong Wang

149 papers receiving 2.5k citations

Hit Papers

Epidemiology of acute myeloid leukemia: Recent progress a... 2019 2026 2021 2023 2019 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rong Wang United States 24 1.1k 799 492 483 395 162 2.6k
Arun S. Shet United States 22 1.1k 0.9× 694 0.9× 678 1.4× 236 0.5× 128 0.3× 61 2.4k
Deepak Bansal India 26 886 0.8× 274 0.3× 526 1.1× 408 0.8× 507 1.3× 248 2.5k
Anders Wåhlin Sweden 30 2.5k 2.1× 1.3k 1.6× 1.1k 2.1× 604 1.3× 683 1.7× 121 3.9k
John‐Bjarne Hansen Norway 40 1.2k 1.0× 631 0.8× 197 0.4× 489 1.0× 136 0.3× 194 4.5k
Brenda Gibson United Kingdom 28 1.8k 1.5× 666 0.8× 366 0.7× 430 0.9× 1.2k 3.1× 74 2.8k
Sigrid K. Brækkan Norway 36 1.1k 0.9× 404 0.5× 213 0.4× 626 1.3× 156 0.4× 167 4.6k
Russell Patmore United Kingdom 26 574 0.5× 463 0.6× 991 2.0× 1.6k 3.3× 801 2.0× 71 3.3k
Marc Ansari Switzerland 26 449 0.4× 538 0.7× 131 0.3× 406 0.8× 566 1.4× 161 2.0k
Barry Meisenberg United States 21 640 0.6× 299 0.4× 141 0.3× 837 1.7× 230 0.6× 68 1.9k
David D. Hurd United States 35 2.4k 2.1× 1.2k 1.5× 808 1.6× 1.6k 3.2× 734 1.9× 159 4.8k

Countries citing papers authored by Rong Wang

Since Specialization
Citations

This map shows the geographic impact of Rong Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rong Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rong Wang more than expected).

Fields of papers citing papers by Rong Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rong Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rong Wang. The network helps show where Rong Wang may publish in the future.

Co-authorship network of co-authors of Rong Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Rong Wang. A scholar is included among the top collaborators of Rong Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rong Wang. Rong Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chu, Lingzhi, Rong Wang, Cary P. Gross, et al.. (2025). Joint Exposure to Ozone and Temperature and Acute Myocardial Infarction Among Adults Aged 18 to 64 Years in the United States. Circulation. 152(4). 246–256. 2 indexed citations
2.
Li, Qifeng, et al.. (2024). A pig behavior-tracking method based on a multi-channel high-efficiency attention mechanism. SHILAP Revista de lepidopterología. 2(4). 100062–100062. 8 indexed citations
3.
Shi, Ming, Yifang He, Jiayao Xu, et al.. (2024). A self-powered theranostic DNA nanodevice for amplification of both intracellular microRNA imaging and photodynamic therapy. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 324. 124987–124987. 1 indexed citations
4.
Wang, Rong, et al.. (2024). USPSTF Colorectal Cancer Screening Recommendation and Uptake for Individuals Aged 45 to 49 Years. JAMA Network Open. 7(10). e2436358–e2436358. 15 indexed citations
5.
Wang, Rong, et al.. (2024). Disparities in Colorectal Cancer Screening Before and After the Onset of the COVID Pandemic. Journal of General Internal Medicine. 40(3). 611–619. 1 indexed citations
6.
Wang, Rong, Yuan Zhang, Minghui Duan, et al.. (2024). Development and validation of a deep learning model for morphological assessment of myeloproliferative neoplasms using clinical data and digital pathology. British Journal of Haematology. 206(2). 596–606. 1 indexed citations
7.
Wang, Rong, Yumeng Jiang, Ziyue Wang, et al.. (2024). Fluoride exposure during puberty induces testicular impairment via ER stress-triggered apoptosis in mice. Food and Chemical Toxicology. 189. 114773–114773. 2 indexed citations
8.
Ji, Mengmeng, Mei Wang, John H. Huber, et al.. (2024). From criteria to clinic: How updated SLiM CRAB criteria influence multiple myeloma diagnostic activity.. Journal of Clinical Oncology. 42(16_suppl). 7556–7556.
9.
Podoltsev, Nikolai A., Rong Wang, Rory M. Shallis, et al.. (2023). Statin use, survival and incidence of thrombosis among older patients with polycythemia vera and essential thrombocythemia. Cancer Medicine. 12(18). 18889–18900. 8 indexed citations
10.
Coté, David J., Rong Wang, Libby M. Morimoto, et al.. (2022). Birth characteristics and risk of meningioma in a population-based study in California. Neuro-Oncology Advances. 4(1). vdac173–vdac173. 3 indexed citations
11.
Metayer, Catherine, Libby M. Morimoto, Joseph L. Wiemels, et al.. (2022). Hispanic Ethnicity Differences in Birth Characteristics, Maternal Birthplace, and Risk of Early-Onset Hodgkin Lymphoma: A Population-Based Case–Control Study. Cancer Epidemiology Biomarkers & Prevention. 31(9). 1788–1795.
12.
Feng, Qianxi, Mi Zhou, Shaobo Li, et al.. (2022). Interaction between maternal killer immunoglobulin-like receptors and offspring HLAs and susceptibility of childhood ALL. Blood Advances. 6(12). 3756–3766. 4 indexed citations
13.
Bewersdorf, Jan Philipp, Nikolai A. Podoltsev, Rory M. Shallis, et al.. (2021). Practice patterns and real-life outcomes for patients with acute promyelocytic leukemia in the United States. Blood Advances. 6(2). 376–385. 9 indexed citations
14.
Wang, Rong, Rory M. Shallis, Jan Philipp Bewersdorf, et al.. (2020). Predictors of Tyrosine Kinase Inhibitor Use Among Older Patients with Chronic Myeloid Leukemia in the United States. Blood. 136(Supplement 1). 13–14. 10 indexed citations
15.
Bewersdorf, Jan Philipp, Rong Wang, Nikolai A. Podoltsev, et al.. (2020). Practice Patterns and Real-Life Outcomes for Patients with Acute Promyelocytic Leukemia. Blood. 136(Supplement 1). 21–22. 1 indexed citations
16.
Zeidan, Amer M., Nikolai A. Podoltsev, Chi Zhang, et al.. (2020). Patterns of care and clinical outcomes with cytarabine-anthracycline induction chemotherapy for AML patients in the United States. Blood Advances. 4(8). 1615–1623. 38 indexed citations
17.
Bewersdorf, Jan Philipp, Smith Giri, Rong Wang, et al.. (2020). Interferon Therapy in Myelofibrosis: Systematic Review and Meta-analysis. Clinical Lymphoma Myeloma & Leukemia. 20(10). e712–e723. 11 indexed citations
18.
Bewersdorf, Jan Philipp, Smith Giri, Rong Wang, et al.. (2020). Interferon alpha therapy in essential thrombocythemia and polycythemia vera—a systematic review and meta-analysis. Leukemia. 35(6). 1643–1660. 39 indexed citations
19.
Zhang, Huihui, Rong Wang, Tingting Shao, et al.. (2019). High expression of miR-363 predicts poor prognosis and guides treatment selection in acute myeloid leukemia. Journal of Translational Medicine. 17(1). 106–106. 11 indexed citations
20.
Jen, Emily Y., Xin Gao, Liang Li, et al.. (2019). FDA Approval Summary: Tagraxofusp-erzs For Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm. Clinical Cancer Research. 26(3). 532–536. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026